These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 25384864)

  • 1. Immunotherapy of multiple sclerosis.
    Meuth SG; Bittner S; Wiendl H
    Acta Neuropsychiatr; 2009 Jun; 21 Suppl 2():27-34. PubMed ID: 25384864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral disease-modifying treatments for multiple sclerosis: the story so far.
    Kieseier BC; Wiendl H
    CNS Drugs; 2007; 21(6):483-502. PubMed ID: 17521228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current treatment of multiple sclerosis].
    Csépány T
    Lege Artis Med; 2011 Feb; 21(2):97-104. PubMed ID: 21710707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral laquinimod treatment in multiple sclerosis.
    Fernández O
    Neurologia; 2011 Mar; 26(2):111-7. PubMed ID: 21163185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral available agents in the treatment of relapsing remitting multiple sclerosis: an overview of merits and culprits.
    Thöne J; Ellrichmann G
    Drug Healthc Patient Saf; 2013; 5():37-47. PubMed ID: 23459383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New oral drugs for multiple sclerosis.
    Gasperini C; Ruggieri S
    Neurol Sci; 2009 Oct; 30 Suppl 2():S179-83. PubMed ID: 19882371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
    Wingerchuk DM; Carter JL
    Mayo Clin Proc; 2014 Feb; 89(2):225-40. PubMed ID: 24485135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunomodulatory treatment strategies in multiple sclerosis.
    Kieseier BC; Wiendl H; Leussink VI; Stüve O
    J Neurol; 2008 Dec; 255 Suppl 6():15-21. PubMed ID: 19300955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emerging oral drugs for relapsing-remitting multiple sclerosis.
    Gasperini C; Ruggieri S
    Expert Opin Emerg Drugs; 2011 Dec; 16(4):697-712. PubMed ID: 22148963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Established and novel disease-modifying treatments in multiple sclerosis.
    Cross AH; Naismith RT
    J Intern Med; 2014 Apr; 275(4):350-63. PubMed ID: 24444048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging oral treatments in multiple sclerosis - clinical utility of cladribine tablets.
    Gasperini C; Ruggieri S; Pozzilli C
    Ther Clin Risk Manag; 2010 Sep; 6():391-9. PubMed ID: 20856685
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging multiple sclerosis oral therapies.
    Rammohan KW; Shoemaker J
    Neurology; 2010 Jan; 74 Suppl 1():S47-53. PubMed ID: 20038763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current and future disease-modifying therapies in multiple sclerosis.
    Lim SY; Constantinescu CS
    Int J Clin Pract; 2010 Apr; 64(5):637-50. PubMed ID: 20456216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral laquinimod therapy in relapsing multiple sclerosis.
    Preiningerova J
    Expert Opin Investig Drugs; 2009 Jul; 18(7):985-9. PubMed ID: 19527103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging oral agents for multiple sclerosis.
    Fox EJ
    Am J Manag Care; 2010 Sep; 16(8 Suppl):S219-26. PubMed ID: 20873946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease-modifying agents in multiple sclerosis.
    O'Connor PW; Oh J
    Handb Clin Neurol; 2014; 122():465-501. PubMed ID: 24507532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune mechanisms of new therapeutic strategies in MS: teriflunomide.
    Claussen MC; Korn T
    Clin Immunol; 2012 Jan; 142(1):49-56. PubMed ID: 21367665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of multiple sclerosis and the place of teriflunomide.
    Gold R; Wolinsky JS
    Acta Neurol Scand; 2011 Aug; 124(2):75-84. PubMed ID: 20880295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment options for multiple sclerosis: current and emerging therapies.
    Gawronski KM; Rainka MM; Patel MJ; Gengo FM
    Pharmacotherapy; 2010 Sep; 30(9):916-27. PubMed ID: 20795847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T; Bereczki D
    Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.